Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06175793 · ClinicalTrials.gov registry record · NA
ASPIRE: Adapting Self-Blood Pressure Monitoring to Reduce Health Disparities
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06175793 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants.
The verdict
NCT06175793, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this study is to implement a pilot focusing on developing training manuals and materials for patients and the clinical team to ensure our intervention is delivered consistently and systematically for each patient.
Interventions
- BEHAVIORAL ASPIRE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06175793
The ClinicalTrials.gov registry entry for NCT06175793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASPIRE Intervention is the first listed.
NCT06175793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06175793 about?
NCT06175793 is a clinical study titled "ASPIRE: Adapting Self-Blood Pressure Monitoring to Reduce Health Disparities". The goal of this study is to implement a pilot focusing on developing training manuals and materials for patients and the clinical team to ensure our intervention is delivered consistently and systematically for each patient.
What is the current status of trial NCT06175793?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-01-15. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT06175793?
The interventions under investigation include: ASPIRE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06175793?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.